Atlas Trials

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

Clinical trial NCT06120842 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06120842
Sponsor
SpyGlass Pharma, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CataractGlaucomaOcular Hypertension
Start date
2023-10-13
Primary completion
2025-01-31
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.